EPSTEIN-BARR VIRUS RELATED CARCINOMA

Clinical trials for EPSTEIN-BARR VIRUS RELATED CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new EPSTEIN-BARR VIRUS RELATED CARCINOMA trials appear

Sign up with your email to follow new studies for EPSTEIN-BARR VIRUS RELATED CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug targets virus behind deadly cancers

Disease control Ongoing

This study is testing an experimental drug called VK 2019 for cancers caused by the Epstein-Barr virus, including nasopharyngeal cancer. It's for patients who have run out of standard treatment options. Researchers will measure if the drug shrinks tumors and monitor its safety an…

Matched conditions: EPSTEIN-BARR VIRUS RELATED CARCINOMA

Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

EPSTEIN-BARR VIRUS RELATED CARCINOMA

Get alerted when new EPSTEIN-BARR VIRUS RELATED CARCINOMA trials appear

New drug targets virus behind deadly cancers